Study of lipid profile in streptozotocin (stz) – induced diabetic rats under nicotinamide coverage treated with ocimum gratissimum (o.g.) and vernonia amygdalina (v.a.)

Chapter ONE

INTRODUCTION

• 1.1Introduction
• 1.2Background of Study
• 1.3Problem Statement
• 1.4Objective of Study
• 1.5Limitation of Study
• 1.6Scope of Study
• 1.7Significance of Study
• 1.8Structure of the Research
• 1.9Definition of Terms

Chapter TWO

LITERATURE REVIEW

• 2.1Overview of Lipid Profile
• 2.2Diabetes and Lipid Profile
• 2.3Streptozotocin (STZ) Induced Diabetes
• 2.4Nicotinamide Coverage in Diabetes Treatment
• 2.5Ocimum Gratissimum (O.G.) in Diabetes Management
• 2.6Vernonia Amygdalina (V.A.) in Diabetes Management
• 2.7Combined Treatment Approaches in Diabetes
• 2.8Effects of O.G. and V.A. on Lipid Profile
• 2.9Studies on Lipid Profile in Animal Models
• 2.10Gaps in Current Literature on Lipid Profile

Chapter THREE

RESEARCH METHODOLOGY

• 3.1Research Methodology Overview
• 3.2Selection of Animal Model
• 3.3Induction of Diabetes in Rats
• 3.4Administration of Nicotinamide Coverage
• 3.5Treatment with O.G. and V.A.
• 3.6Measurement of Lipid Profile Parameters
• 3.7Data Collection and Analysis Methods
• 3.8Statistical Analysis Techniques

Chapter FOUR

DATA PRESENTATION AND ANALYSIS

• 4.1Lipid Profile Changes in Diabetic Rats
• 4.2Effects of Nicotinamide Coverage
• 4.3Impact of O.G. Treatment
• 4.4Influence of V.A. Treatment
• 4.5Combined Effects of O.G. and V.A.
• 4.6Comparison with Control Group
• 4.7Discussion on Lipid Profile Findings
• 4.8Implications for Diabetes Management

Chapter FIVE

SUMMARY, CONCLUSION AND RECOMMENDATIONS

• 5.1Summary of Research Findings
• 5.2Conclusion and Interpretation
• 5.3Contributions to Diabetes Research
• 5.4Recommendations for Future Studies
• 5.5Practical Applications in Healthcare